摘要 |
<p>The present invention relates to certain 3-[4-(substituted Heterocyclyl)-pyrrol-2-ylmethylidene]-2-Indolinone derivatives that inhibit kinases, in particular VEGFR and/or PDGFR kinases. Pharmaceutical compositions comprising these compounds, methods of treating diseases mediated by kinases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing them are also disclosed.</p> |